ArticleOphthalmology and therapy2025

Pooled Multicenter Safety Analysis of Lupin's Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases.

Debdulal Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.